SEC Company Response from OptimizeRx Corp (OPRX) (CIK 0001448431) (OPRX) — Feb 11, 2009

OptimizeRx Corp (OPRX) (CIK 0001448431)
Date: Feb. 11, 2009 · CIK: 0001448431 · Accession: 0001361106-09-000053

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-155280

Referenced dates: February 11, 2009

Date

Feb. 11, 2009

Author

Not clearly detected

Form

CORRESP

Company

OptimizeRx Corp (OPRX) (CIK 0001448431)

Letter

optimizerx_corresp-021109.htm

OPTIMIZERX CORPORATION

SIXTH STREET

ROCHESTER, MI 48307

February 12, 2009

VIA FACSIMILE (202-772-9210) AND EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: David Orlic, Special Counsel

Re: OptimizeRx Corporation

Registration Statement on Form S-1

File No. 333-155280

Ladies and Gentlemen:

We hereby withdraw our acceleration letter dated February 11, 2009 and hereby replace such letter with this request. Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), OptimizeRX Corporation (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 11:00 a.m., Eastern Time, Thursday, February 12, 2009 or as soon thereafter as possible

We hereby acknowledge the following:

that should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

OptimizeRX Corporation

By:

/s/ David A Harrell

Name: David A Harrell

Title: Chief Executive Officer

Show Raw Text

CORRESP
1
filename1.htm

    optimizerx_corresp-021109.htm

    OPTIMIZERX
CORPORATION

    407
SIXTH STREET

    ROCHESTER,
MI 48307

    February
12, 2009

    VIA FACSIMILE (202-772-9210)
AND EDGAR

    United
States Securities and Exchange Commission

    100 F
Street, N.E.

    Washington,
D.C. 20549

    Attention:  David
Orlic, Special Counsel

    Re:         OptimizeRx
Corporation

    Registration Statement on Form
S-1

    File
No. 333-155280

    Ladies
and Gentlemen:

    We hereby withdraw our acceleration
letter dated February 11, 2009 and hereby replace such letter with this request.
Pursuant to Rule 461 of the General Rules and Regulations under the Securities
Act of 1933, as amended (the “Act”), OptimizeRX Corporation (the “Company”)
respectfully requests that the effective date of the registration statement
referred to above be accelerated so that it will become effective at 11:00 a.m.,
Eastern Time, Thursday, February 12, 2009 or as soon thereafter as
possible

    We hereby
acknowledge the following:

              ·

              that
      should the Commission or the staff, acting pursuant to delegated
      authority, declare the filing effective, it does not foreclose the
      Commission from taking any action with respect to the
    filing;

              ·

              the
      action of the Commission or the staff, acting pursuant to delegated
      authority, in declaring the filing effective, does not relieve the Company
      from its full responsibility for the adequacy and accuracy of the
      disclosure in the filing; and

              ·

              the
      Company may not assert staff comments and the declaration of effectiveness
      as a defense in any proceeding initiated by the Commission or any person
      under the federal securities laws of the United
  States.

              OptimizeRX
      Corporation

                By:

              /s/
      David A Harrell

              Name:
              David
      A Harrell

              Title:
              Chief
      Executive Officer

SecProbe.io